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ABSTRACT 
In the body under physiological conditions, many vital 
functions are regulated by transient release of bioactive 
substances at a specific time and site. Thus, to mimic the 
function of living systems and in view of emerging 
chronotherapeutic approaches, which lead to development 
of pulsatile system that release a therapeutic agent at a 
rhythm that  ideally matches the biological requirement of a 
given disease therapy. Diseases where a constant drug 
levels are not preferred, but needs a pulse of therapeutic 
concentration in a periodic manner  and diseases with 
established oscillatory rhythm in their pathogenesis 
includes asthma, arthritis, duodenal ulcer, cancer, 
cardiovascular diseases acts as a push for the development 
of “Pulsatile Drug Delivery Systems “. In these systems, 
there is rapid and transient release of a certain amount of 
drug molecules within a short time-period immediately 
after a predetermined off release period. Various techniques 
are available for the pulsatile delivery like pH dependent 
systems, time dependent systems, etc. Pulsatile drug 
delivery system providing special and temporal delivery 
and increasing patient compliance. Pulsatile drug delivery 
system is defined as the rapid and transient release of 
certain amount of molecules within a short time period 
immediately after predetermined off-release periods i.e. lag 
time. Advantages of the pulsatile drug delivery system are 
reduced dose frequency; reduce side effects, drug targeting 
to specific site like colon and many more. Now in market 
varies technologies of pulsatile drug delivery system like 
OROS, CODAS etc. are launched by pharmaceutical 
companies. 
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INTRODUCTION 
Nowadays, the emphasis of pharmaceutical galenic 
research is turned towards the development of more 
efficacious drug delivery systems with already existing 
molecule rather going for new drug discovery becauseof 
the inherent hurdles posed in drug discovery and 
development process[1]. 
Pulsatile system is amongst one of them and gaining a lot 
of interest as it is increasing patient compliance by means 
of providing time- and site-specific drugdelivery system, 
thus providing special and temporal delivery. A 
pharmaceutical dosage form such as a capsule capable of 
delivering therapeutic agents into the body in a time-
controlled or position-controlled pulsatile release fashion, 
is composed of a multitude of multicoated particulates 
(beads, pellets,granules, etc.) made of one or more 
populations of beads. On which cases or circumstance 
pulsatile drug delivery is used they are listed below. 
1) Chronopharmacotherapy of diseases which 
shows circadian rhythms in their 
pathophysiology. 
2) Avoiding the first pass metabolism e.g. 
protein and peptides[2] 
3) For which the tolerance is rapidly exists, 
4) For targetting specific site in intestine e.g. 
colon, 
5) For time programmed administration of 
hormone and drugs, 
6) For drugs having the short half life 
Drugs which exhibit tolerance should not be delivered at a 
constant rate, since the drug effect decreases with time at 
constant drug level. In addition drug toxicity increases with 
time when drug levels are held constant. In such cases it is 
preferable to opt for dosage form which will provide 
desired concentration of drug at particular time point 
only[3]. Now, concept of chronopharmaceutics has 
emerged, wherein, research is devoted to the design and 
evaluation of drug delivery systems that release a 
therapeutic agent at a rhythm that ideally matches the 
biological requirement of a given disease therapy. 
“Chronopharmaceutics” consist of two words 
chronobiology and pharmaceutics. Chronobiology is the 
study of biological rhythms and their mechanisms. 






This word comes from Latin word “circa” means about and 
“dies” means day 
Ultrdian 
Oscillation of shorter duration are termed as ultradian 
(more than one cycle per 24 h) 
Infradian 
Oscillations that are longer than 24 h (less than one cycle 
per day)Diseases where a constant drug levels are not 
preferred, but needs a pulse of therapeutic concentration in 
a periodic manner acts as a push for the development of 
“Pulsatile Drug Delivery Systems”[4]. 
The diseases that are targeted for chronopharmaceutics are 
those which establish oscillatory rhythm in their 
pathogeneisis. These diseases include asthma, arthritis, 
duodenal ulcer, cancer, cardiovascular diseases (e.g., 
hypertension and acute myocardial infarction, 
hypercholesterolemia, and ulcer). 
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EXPERIMENTAL MATERIAL AND 
METHODS 
Two different methods have been investigated to 
induce the pulsatile release of therapeutic agents. 
One method is the elaboration of pre programmed 
delivery systems in which the drug is released at a 
predetermined time or in pulses of known 
sequence. A second method is the production of 
system that responds to specific stimuli.  
 
Classification of Pulsatile Drug Dilevery System 
(PDDS) 
 PDDS is divided into two systems 
A.  Pre Planned System 
B.  Stimulus Induced Systems 
 
A. Pre planned systems 
1. Pulsatile system based on capsule 
2. Pulsatile system based on osmosis  
3. Drug delivery system with erodible or soluble 
layer 
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Pulsatile System Based On Capsule 
Capsule based system consists of pulsincap system, which consists 
of an insoluble capsule body and swellable and degradable plugs 
made of approved substances such as hydrophilic polymers or lipids 
(Krogel et al.1998; Krogel et al. 1999). The lag time is controlled by 
plug, which pushed away by swelling or erosion and drug is 
released as a pulse from the insoluble capsule i.e. Pulsincap®. A 
swellable hydrogel plug seals the drug contents in to capsule body. 
When this capsule body came in to contact with dissolution 
medium, the hydrogel plug swells, and after the lag time the plug 
pushed itself outside the capsule and rapidly released the 
drug. Various types of material used for formulation of 
swellable plug which include hydroxyl propyl methl 
cellulose, poly vinyl acetate and poly ethylene oxide. The 
length of plug decides lag time.[5,6]  There are another two 
approaches, one is generation of hydrostatic pressure by 
using biodegradable capsule of poly (lactic acid) (PLA) 
containing the drug along with citric acid / sodium 
bicarbonate and glucose was prepared. Thin poly (lactide-
co-glycolide) (PLGA) membrane (to allow water 
penetration inside the capsule) was utilized on one end. 
Water penetrates into the capsule through the thin poly 
(lactide-co-glycolide) (PLGA) membrane side, which 
generates effervescence due to reaction caused between the 
citric acid and sodium bicarbonate, generating carbon 
dioxide gas. Onther approach is pulsincap for position 
controlled pulsatile release [7] which ia achevied by using 
coatin membranes. One of the coating membranes is 
composed of an enteric polymer and the second membrane 
barrier is composed of a mixture of water-insoluble 
polymer and an enteric polymer. The composition and the 
thickness of the polymeric membranes determine the lag 
time and the duration of the drug release from each of the 
bead populations. In other preparations, an organic acid 
such as fumaric acid, citric acid, succinic acid, tartaric acid 
or malic acid, is included and a maleic acid containing 
membrane may be provided between the first and second 
membrane layers to provide for the time-separated pulses. 
The acids in between the membranes may delay the 
dissolution of the enteric polymer in the inner layer, 
thereby increasing the lag time as well as decreasing the 
rate of release of the active ingredient from the coated 
microparticulates. The enteric coating membrane is 
generally incorporated in the innermost layer to have the 
drug released in the lower intestine.  
Pulsatile System Based On Osmosis 
Osmotic system consists of capsule coated with the 
semipermiable membrane.In this system for development 
of osmotic pressure different techniques are used. 
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Case 1: Osmotic system containing insoluble plug, Osmotic 
system consists of capsule coated with the semipermiable 
membrane. Inside the capsule was an insoluble plug, 
osmotically active agent and the drug formulation. When 
this capsule came in contact with the body fluid, the 
semipermeable membrane. 
Case 2: Osmotic system based on expandable orifice 
technology, Linkwitz et al. invented tThe system is in the 
form of capsule from which the drug is delivered by the 
capsule’s osmotic infusion of moisture from the body. The 
delivery orifice opens intermittently to achieve pulsatile 
delivery effect. The orifice forms in the capsule wall, which 
is constructed of an elastic material, preferably elastomer 
(eg. Styrene-butadiene copolymer), which stretches under a 
pressure differential caused by the pressure rise inside the 
capsule. 
Case 3:  Osmotic capsule containing micropores, 
Niwa et al. invented A novel capsule made from ethyl 
cellulose for time-controlled release of drugs in the 
colon.[11] Initially, the capsule was prepared by using a 
gelatin capsule with ethyl cellulose. The thickness of 
ethyl cellulose capsule body was varied and the effect 
of the wall thickness on the release of the drug in the 
capsules was investigated. The ethyl cellulose 
capsules contained a large number of mechanically 
made micropores (400 μm) at the bottom. A swellable 
layer consisting of lowsubstituted hydroxy propyl 
cellulose (L-HPC) was located in the bottom of capsule 
body. Above the swellable layer was the drug reservoir 
which contained mixture of model drug, fluorescein and a 
bulking agent, such as lactose and starch. The capsule was 
then capped and sealed with a concentrated ethyl cellulose 
solution. After administration of the drugcontaining 
capsule, water molecules penetrated the capsule through the 
micropores in the bottom of the capsule body. Hydration 
and swelling of the L-HPC induced an increase in the 
internal osmotic pressure, which resulted in the “explosion” 
of the capsule and a burst-like drug release was observed. 
The lag time of the drug release could be altered by altering 
the thickness of the capsule[9]. 
Drug Delivery System With Erodible Or Soluble 
Layer 
In such systems the drug release is controlled by the 
dissolution or erosion of the outer coat which is 
applied on the core containing drug. Time dependent 
release of the active ingredient can be obtained by 
optimizing the thickness of the outer coat[10] e.g 
chronotropic system which consists of a drug containing 
core layered with HPMC optionally coated with an outer 
enteric coating. The lag time prior to drug release is 
controlled by the thickness and the viscosity grade of 
HPMC layer [11]. 
The time clock system is a delivery device based on solid 
dosage form that is coated by an aqueous dispersion[12]. 
This coating is a hydrophobic-surfactant layer to which a 
water-soluble polymer is added to improve adhesion to the 
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core. Once in contact with the dissolution fluid, the 
dispersion rehydrates and redisperses. The lag time could 
be controlled by varying the thickness of the film. This 
system has shown reproducible results in vitro and in vivo. 
The effect of low calorie and high calorie meal on the lag 
time was studied using gamma scintigraphy. The mean lag 
time of drug release was 345 and 333 min, respectively.  
Pulsatile release tablet was developed that can suppress 
release of the drug in the stomach and can release the drug 
rapidly after a predetermined time of about 3 hrs in the 
intestine. The system consists of a core, swelling agent of 
cross linked PVP and a coating film of ethyl cellulose/ 
Eudragit L. Eudragit L dissolves in an environment of pH 
above 6 and creates pores in the coating film. Penetration 
of water molecules from the surroundings through the pores 
in to the core causes expansion of the swelling agent, 
bursting the film and releasing the drug with a single pulse. 
Manipulation of the thickness of coating film can control 
the lag time.  
Drug Delivery System With Rupturable Layers/ 
Membranes 
These systems consist of an outer release controlling water 
insoluble but permeable coating subject to mechanically 
induced rupture phenomenon. Recently different systems 
based on hard gelatin capsules and tablet core were 
described, all coated by inner swellable and outer 
rutpurable layer. The film rupture may be attained by 
including swelling, osmotic or effervescent additives in the 
reservoir[13]. 
Bussemer et al. worked on a pulsatile system with 
rupturable coating on drug present in hard gelatin capsules. 
These capsules were first coated with a swelling layer and 
then with an insoluble but water-permeable outer coating. 
These coated capsules when immersed in the release media 
could take up the media at a constant rate up to a point 
when the outer coating would rupture because of the 
pressure caused by the swelling layer. It could be 
concluded that by increasing the swelling layer, the lag 
time could be shortened. However, by increasing the outer 
coating, the lag time could be prolonged. It was also 
observed that addition of HPMC to the outer coating 
shortens the lag time[
14]
. 
A pharmaceutical implant was developed for biologically 
active material, an excipient comprising at least one 
watersoluble material and above which polymer film 
coating adapted to rupture at predetermined period of time 
after implantation[15] In one form, a bilayer film coating 
forms an impermeable barrier to the drug. An insoluble 
outer film controls the degree of access of physiological 
film to the inner film. A film coating comprising a mixture 
of ethyl cellulose and a copolymer of glycolic and lactic 
acids is used. As ethyl cellulose is an insoluble polymer, 
when the polylactic glycolic acid (PLGA) polymer in the 
film hydrolyses, the film becomes porous and allows 
release of the drug. The rate of hydrolysis of the PLGA 
depends on the ratio of the lactic acid to glycolic acid in the 
polymer. 
The multi unit systems which produce more then one pulse 
are also possible and some companies like Eurand Ltd. are 
working this direction. Generally two or three pulse 
creations are possible. Almost erodible layer and rupturable 
layer system are used for more than one pulse creation and 
are almost same like the single unit system described 
above. 
 
B. STIMULI INDUCED PULSATILE SYSTEMS 
I. Temperature induced system 
II. Chemically induced System 
III.  Externally induced System 
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I. Temperature Induce System 
Thermo-responsive hydrogel systems have been developed 
for pulsatile release. In these systems the polymer 
undergoes swelling or deswelling phase in response to the 
temperature which modulate drug release in swollen 
state[16]. Y.H. Bae et al developed indomethacin pulsatile 
release pattern in the temperature ranges between 200C and 
300C by using reversible swelling properties of copolymers 
of N-isopropylacrylamide and butyrylacrylamide. Kataoka 
et al developed the thermosensitive polymeric micelles as 
drug carrier to treat the cancer. They used 
endfunctionalized poly(N-isopropylacrylamide) (PIPAAm) 
to prepare corona of the micelle which showed hydration 
and dehydration behavior with changing temperature[17]. 
II. Chemically Induced System 
There has been much interest in the development of 
stimuli-sensitive delivery systems that release a therapeutic 
agent in presence of specific enzyme or protein. One 
prominent application of this technology has been 
development of a system that can autonomously release 
insulin in response to elevated blood glucose levels. 
Several existing strategies that may be feasible for glucose-
responsive drug delivery are discussed below: pH-
dependent systems for Glucose stimulated drug delivery are 
based on the reaction that glucose oxidase catalyses 
oxidation of glucose to gluconic acid. This reaction can be 
used to drive the swelling of pH-dependent membrane. A 
dual membrane system was formed. In the first membrane, 
glucose oxidase was immobilized on cross linked 
polyacrylamide and this was referred to as glucose sensing 
membrane. Co-polymer membrane composed of N, N- 
diethylaminoethyl methacrylate and 2-hydroxypropyl 
methacrylate (DEA-HPMA) formed the barrier membrane 
and worked as an interface between insulin reservoir and 
sensing membrane[18]. 
In pH sensitive system there are two components 
one is of immediate release type and other one is pulsed 
release which releases the drug in response to change in 
pH. In case of pH dependent system advantage has been 
taken of the fact that there exists different pH environment 
at different parts of the gastrointestinal tract. By selecting 
the pH dependent polymers drug release at specific location 
can be obtained. Examples of pH dependent polymers 
include cellulose acetate phthalate, polyacrylates, and 
sodium carboxymethyl cellulose. These polymers are used 
as enteric coating materials so as to provide release of drug 
in the small intestine. Yang et al developed pH-dependent 
delivery system of nitrendipine in which they have mixed 
three kinds of pH dependent microspheres made up of 
acrylic resins Eudragit E-100, 
Hydroxypropylmethylcellulose phthalate and 
Hydroxypropylmethylcellulose acetate succinate as pH 
dependent polymers. In one of the study carried out by 
Mastiholimath et al attempt was made to deliver 
theophylline into colon by taking the advantage of the fact 
that colon has a lower pH value (6.8) than that of the small 
intestine (7.0–7.8). So, by using the mixture of the 
polymers, i.e. Eudragit L and Eudragit S in proper 
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Table 1. Marketed Technologies of Pulsatile Drug Delivery System 
Technology Mechanism API Disease Reference 
Pulsys® Timed-controlled 
System 
Amoxicillin  pharyngitis/tonsillitis 27 
Uniphyl® Externally regulated 
System 
Theophylline Asthma  27 





Oxymorphone Pain medicine 28 
TheirForm® Externally regulated 
system 
Diclofenac sodium Inflammation 29 
 
III. Externally Stimuli System 
For releasing the drug in a pulsatile manner, another 
way can be the externally regulated systems in which drug 
release is programmed by external stimuli like magnetism, 
ultrasound, electrical effect and irradiation. 
1. Magnetically Stimulated 
 Saslawski et al.[19] developed different 
formulations for in vitro magnetically triggered delivery of 
insulin based on alginate spheres. In an experiment, ferrite 
microparticles (1µm) and insulin powder were dispersed in 
sodium alginate aqueous solution. The  ferrite-insulin 
alginate suspension was later dropped in aqueous calcium 
chloride solution which causes  the formation of cross 
linked alginate spheres, which were further cross linked 
with aqueous solution of  poly(L-lysine) or poly(ethylene 
imine). They described that the magnetic held 
characteristics due to the ferrite microparticles and the 
mechanical properties of the polymer matrices could play 
role in controlling the release rates of insulin from the 
system. US Patent 2006 997863[20] provides a treatment 
method  that involves the administration of a magnetic 
material  composition, which contains single-domain 
magnetic particles attached to a target-specific ligand, to a  
patient and the application of an alternating magnetic  field 
to inductively heat the magnetic material  composition, 
which cause the triggered release of  therapeutic agents at 
the target tumor or cancer cells. 
2. Ultrasonically Stimulated  
Ultrasound is mostly used as an enhancer for the 
improvement of drug permeation through biological 
barriers, such as skin, lungs, intestinal wall and blood 
vessels. There are several reports describing the effect of 
ultrasound on controlled drug delivery. Kost et al. 
described an ultrasound-enhanced polymer degradation 
system. During polymer degradation incorporated drug 
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molecules were released by repeated ultrasonic exposure. 
As degradation of biodegradable matrix was enhanced by 
ultrasonic exposure, the rate of drug release also increased. 
Thus, pulsed drug delivery was achieved by the on-off 
application of ultrasound[21]. Miyazaki et at. [22] used 
ultrasound to achieve up to a 27-fold increase in the release 
of 5-fluorouracil from an ethylene and vinyl acetate (EVAc) 
matrix.Increasing the strength of the ultrasound resulted in a 
proportional increase in the amount of 5-fi uorouracil 
released. 
3. Photo Stimulated 
The interaction between light and material can be used to 
modulate drug delivery. This can be accomplished by 
combining a material that absorbs light at a desired 
wavelength and a material that uses energy from the 
absorbed light to modulate drug delivery. Embedding the 
nanoshells in a NIPAAm-co-AAM hydrogel formed the 
required composite material. When exposed to near-
infrared light, nanoshells absorb the light and convert it to 
heat, raising the temperature of composite hydrogel above 
its LCST. That’s result in the increase rate release of the 
drug from matrix system[23]. 
4. Electrically stimulated 
An electricfield as an external stimulus has advantages such 
as availability of equipment, which allows precise control 
with regards to the magnitude of the current, duration of 
electric pulses, interval between pulses etc. Electrically 
responsive delivery systems are prepared from 
polyelectrolytes and are thus pH- responsive as well as 
electro responsive. Under the infi uence of electric › eld, 
electro responsive hydrogels generally deswell, swell or 
erode. Poly(2-acrlamide-2-methylpropanesulfonic acid-co- 
butyl methacrylate) (P(AMPS-co-BMA) hydrogels were 
used for electric stimuli-induced drug delivery system[25,26]. 
Positively charged edrophonium chloride was incorporated 
as drug molecule within negatively charged P(AMPS-co-
BMA) hydrogels. By applying an electric  › eld, ion 
exchange between edrophonium ions and protons 
commenced at cathode, resulting in rapid drug release from 
hydrogels. This rapid drug release was attributed to the 
electrostatic force, squeezing effect, and electro-osmosis of 
the gel. Complete on-off drug release was achieved, as no 
drug release was apparent without the application of electric 
current. 
MODERN DEVELOPMENT ON PULSATILE 
SYSTEMNowadays pulsatile drug delivery systems are 
gaining importance in various disease conditions 
specifically in diabetes where dose is required at different 
time intervals. Among these systems, multi-particulate 
systems (e.g. pellets) offer various advantages over single 
unit which include no risk of dose dumping, flexibility of 
blending units with different release patterns, as well as 
short and reproducible gastric residence time. 
Multiparticulate systems consists pellets of different release 
profile which can be of any type like time dependent, pH 
dependent, micro flora activated system as discussed in the 
previous sections. Site and time specific oral drug delivery 
have recently been of great interest in pharmaceutical field 
to achieve improved therapeutic efficacy. Gastroretentive 
drug delivery system is an approach to prolong gastric 
residence time, thereby targeting sitespecific drug release in 
upper gastrointestinal (GI) tract. Floating drug delivery 
system (FDDS) and bioadhesive drug delivery are widely 
used techniques for gastro retention. Low density porous 
multiparticulate systems have been used byresearchers for 
formulation of FDDS. Sharma and Pawar developed 
multiparticulate floating pulsatile drug delivery system 
using porous calcium silicate and sodium alginate for time 
and site specific drug release of meloxicam. Various 
pulsatile technologies have been developed on the basis of 
methodologies as discussed previously. These includes 
OROS® technology, CODAS® technology, CEFORM® 
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technology, DIFFUCAPS® technology, Three-dimensional 
printing®, timerx® etc. Table.2 summarizes the 
technologies of pulsatile drug delivery. 
CONCLUSION 
There is a constant need for new delivery systems 
that can provide increased therapeutic benefits to the 
patients. Circadian rhythm of the body is an important 
concept for understanding the optimum need of drug in the 
body. Pulsatile drug delivery is one such system that, by 
delivering drug at the right time, right place & in right 
amounts, holds good promises of benefit to the patients 
suffering from chronic problems like arthritis, asthma, 
hypertension, etc.Thus, designing of proper pulsatile drug 
delivery will enhance the patient compliance, optimum 
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